CN Patent

CN112409349A — 激酶抑制剂及其制备、药物组合物和用途

Assigned to HUNAN NEW MEDICAL SCIENCE AND · Expires 2021-02-26 · 5y expired

What this patent protects

本申请涉及可作为激酶抑制剂(如酪氨酸激酶抑制剂)的式I化合物、其制备方法以及包含所述式I化合物的药物组合物。本申请还涉及所述式I化合物或其药物组合物在免疫疾病、肿瘤和神经疾病等疾病中的治疗用途。

USPTO Abstract

本申请涉及可作为激酶抑制剂(如酪氨酸激酶抑制剂)的式I化合物、其制备方法以及包含所述式I化合物的药物组合物。本申请还涉及所述式I化合物或其药物组合物在免疫疾病、肿瘤和神经疾病等疾病中的治疗用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN112409349A
Jurisdiction
CN
Classification
—
Expires
2021-02-26
Drug substance claim
No
Drug product claim
No
Assignee
HUNAN NEW MEDICAL SCIENCE AND
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.